4.3 Review

DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer

Publisher

WILEY
DOI: 10.1002/wsbm.89

Keywords

-

Ask authors/readers for more resources

Epigenetics refers to heritable modifications of the genome that are not a result of changes in the DNA sequence and result in phenotypic changes. These changes can be stably transmitted through cell division and are potentially reversible. Epigenetic events are very important during normal development wherein a single progenitor cell proliferates and differentiates into various somatic cell types. This process occurs through modification of the genome without changing the genetic code. Because epigenetic control of gene expression is so important, aberrant epigenetic regulation can lead to disease and cancer. This article reviews epigenetic changes seen in cancer by examining epigenetic changes commonly found in multiple myeloma, a common hematologic malignancy of plasma cells. Epigenetic control of gene expression can be exerted by changes in DNA methylation, histone modifications, and expression of noncoding RNAs. Each of these regulatory mechanisms interacts with the others at different genomic locations and can be measured quantitatively within the cell, requiring that we consider these mechanisms not individually but as a biological system. DNA methylation was the earliest discovered epigenetic regulator and has been the focus of most investigations in cancer. We have thus focused on DNA methylation changes in the pathogenesis of multiple myeloma, which promises to become an excellent model for systems biological studies of epigenomic dysregulation in human disease. (C) 2010 John Wiley & Sons, Inc. WIREs Syst Biol Med 2010 2 654-669

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Preleukemic and leukemic evolution at the stem cell level

Jacob Stauber, John M. Greally, Ulrich Steidl

Summary: This review discusses the role of clonal evolution in hematological malignancies and emphasizes the contribution of the hematopoietic stem cell population in disease progression and relapse. Recent advances and unanswered questions in this field are highlighted.

BLOOD (2021)

Article Medicine, Research & Experimental

The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children

Jacqueline A. Odgis, Katie M. Gallagher, Sabrina A. Suckiel, Katherine E. Donohue, Michelle A. Ramos, Nicole R. Kelly, Gabrielle Bertier, Christina Blackburn, Kaitlyn Brown, Lena Fielding, Jessenia Lopez, Karla Lopez Aguiniga, Estefany Maria, Jessica E. Rodriguez, Monisha Sebastin, Nehama Teitelman, Dana Watnick, Nicole M. Yelton, Avinash Abhyankar, Noura S. Abul-Husn, Aaron Baum, Laurie J. Bauman, Jules C. Beal, Toby Bloom, Charlotte Cunningham-Rundles, George A. Diaz, Siobhan Dolan, Bart S. Ferket, Vaidehi Jobanputra, Patricia Kovatch, Thomas V. McDonald, Patricia E. McGoldrick, Rosamond Rhodes, Michael L. Rinke, Mimsie Robinson, Arye Rubinstein, Lisa H. Shulman, Christian Stolte, Steven M. Wolf, Elissa Yozawitz, Randi E. Zinberg, John M. Greally, Bruce D. Gelb, Carol R. Horowitz, Melissa P. Wasserstein, Eimear E. Kenny

Summary: The NYCKidSeq project aims to contribute innovations and best practices in communicating genomic test results to diverse populations, providing information for implementing genomic medicine in health systems serving diverse populations using methods that are clinically useful, technologically savvy, culturally sensitive, and ethically sound.

TRIALS (2021)

Article Genetics & Heredity

GUiA: a digital platform to facilitate result disclosure in genetic counseling

Sabrina A. Suckiel, Jaqueline A. Odgis, Katie M. Gallagher, Jessica E. Rodriguez, Dana Watnick, Gabrielle Bertier, Monisha Sebastin, Nicole Yelton, Estefany Maria, Jessenia Lopez, Michelle Ramos, Nicole Kelly, Nehama Teitelman, Faygel Beren, Tom Kaszemacher, Kojo Davis, Irma Laguerre, Lynne D. Richardson, George A. Diaz, Nathaniel M. Pearson, Stephen B. Ellis, Christian Stolte, Mimsie Robinson, Patricia Kovatch, Carol R. Horowitz, Bruce D. Gelb, John M. Greally, Laurie J. Bauman, Randi E. Zinberg, Noura S. Abul-Husn, Melissa P. Wasserstein, Eimear E. Kenny

Summary: Genomic sequencing is increasingly used to meet the needs of a growing patient population, and GUiA, a web-based application, was developed to effectively deliver genomic results and clinical information. Feedback from NYCKidSeq participants showed positive responses to GUiA, suggesting its utility in communicating complex genomic information effectively among diverse populations.

GENETICS IN MEDICINE (2021)

Article Biochemistry & Molecular Biology

Cell type-specific chromatin accessibility analysis in the mouse and human brain

Devin Rocks, Ivana Jaric, Lydia Tesfa, John M. Greally, Masako Suzuki, Marija Kundakovic

Summary: ATAC-seq is a popular method in neuroscience research, offering advantages of requiring minimal material and capturing a variety of gene regulatory elements. Different freezing methods can impact the results but overall, ATAC-seq coupled with FANS generates consistent and robust data for studying neuronal chromatin accessibility.

EPIGENETICS (2022)

Article Mathematical & Computational Biology

Subgroup discovery in non-inferiority trials

Melissa J. Fazzari, Mimi Y. Kim

Summary: This study examined approaches and guidelines for subgroup analysis to assess heterogeneity of treatment effect in clinical trials, with a focus on non-inferiority (NI) trials. It found that standard statistical tests and machine learning methods have different applications and performances in subgroup analysis, helping to understand the underlying reasons for trial outcomes.

STATISTICS IN MEDICINE (2021)

Article Oncology

The Genomics of Colorectal Cancer in Populations with African and European Ancestry

Parvathi A. Myer, Jessica K. Lee, Russell W. Madison, Kith Pradhan, Justin Y. Newberg, Carmen R. Isasi, Samuel J. Klempner, Garrett M. Frampton, Jeffery S. Ross, Jeffrey M. Venstrom, Alexa B. Schrock, Sudipto Das, Leonard Augenlicht, Amit Verma, John M. Greally, Srilakshmi M. Raj, Sanjay Goel, Siraj M. Ali

Summary: Black people have a higher incidence and worse survival rates for colorectal cancer compared to white people. African descent patients have more frequent genetic alterations, particularly in KRAS, APC, and PIK3CA genes. In young-onset colorectal cancer, there are significant differences in APC mutations between African descent and European descent patients.

CANCER DISCOVERY (2022)

Article Endocrinology & Metabolism

Vitamin D Deficiency During Development Permanently Alters Liver Cell Composition and Function

Kassidy Lundy, John F. Greally, Grace Essilfie-Bondzie, Josephine B. Olivier, Reanna Dona-Termine, John M. M. Greally, Masako Suzuki

Summary: Vitamin D plays a critical role in calcium homeostasis, the immune system, and normal development. Many global epidemiological studies have found high prevalence rates of vitamin D deficiency and insufficiency, particularly in reproductive age and pregnant women. This study using a mouse model found that prenatal vitamin D deficiency increases the occurrence of liver histopathological changes and alters gene expression profiles, potentially contributing to offspring health risks.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Genetics & Heredity

Recommendations for clinical interpretation of variants found in non-coding regions of the genome

Jamie M. Ellingford, Joo Wook Ahn, Richard D. Bagnall, Diana Baralle, Stephanie Barton, Chris Campbell, Kate Downes, Sian Ellard, Celia Duff-Farrier, David R. FitzPatrick, John M. Greally, Jodie Ingles, Neesha Krishnan, Jenny Lord, Hilary C. Martin, William G. Newman, Anne O'Donnell-Luria, Simon C. Ramsden, Heidi L. Rehm, Ebony Richardson, Moriel Singer-Berk, Jenny C. Taylor, Maggie Williams, Jordan C. Wood, Caroline F. Wright, Steven M. Harrison, Nicola Whiffin

Summary: This article discusses genetic variants in non-coding regions and proposes guidelines for defining and interpreting these variants. The aim of these guidelines is to increase the number and range of non-coding region variants that can be clinically interpreted, leading to new diagnoses and the discovery of novel disease mechanisms.

GENOME MEDICINE (2022)

Review Hematology

Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications

Patricia A. Shi, Larry L. Luchsinger, John M. Greally, Colleen S. Delaney

Summary: This review discusses the decline in the use of umbilical cord blood (UCB) as a source of donor hematopoietic stem cells (HSC) for transplantation and emphasizes the potential of UCB and related birthing tissues for a wide range of therapies. When best practices are followed, UCB transplant can provide better survival and decreased risks compared to other donor sources. The review suggests that the potential of UCB for transplant and other cell-based therapies is undervalued and underutilized.

CURRENT OPINION IN HEMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Expansion and mechanistic insights into de novo DEAF1 variants in DEAF1-associated neurodevelopmental disorders

Stacey R. McGee, Shivakumar Rajamanickam, Sandeep Adhikari, Oluwatosin C. Falayi, Theresa A. Wilson, Brian J. Shayota, Jessica A. Cooley Coleman, Cindy Skinner, Raymond C. Caylor, Roger E. Stevenson, Caio Robledo D' Angioli Costa Quaio, Berenice Cunha Wilke, Jennifer M. Bain, Kwame Anyane-Yeboa, Kaitlyn Brown, John M. Greally, Emilia K. Bijlsma, Claudia A. L. Ruivenkamp, Keren Politi, Lydia A. Arbogast, Michael W. Collard, Jodi Huggenvik, Sarah H. Elsea, Philip J. Jensik

Summary: De novo deleterious and heritable biallelic mutations in the DNA binding domain of DEAF1 result in a phenotypic spectrum of neurodevelopmental disorders, affecting genes involved in neuronal function and dendritic spine maintenance. This study expands the clinical spectrum of individuals with DEAF1-associated neurodevelopmental disorders, enhances our understanding of DEAF1's potential roles in neuronal function, and demonstrates the dominant negative activity of de novo variants.

HUMAN MOLECULAR GENETICS (2023)

Article Multidisciplinary Sciences

Genomic insights into host and parasite interactions during intracellular infection by Toxoplasma gondii

Netha Ulahannan, Ronald Cutler, Reanna Dona-Termine, Claudia A. Simoes-Pires, N. Ari Wijetunga, Matthew McKnight Croken, Andrew D. Johnston, Yu Kong, Shahina B. Maqbool, Masako Suzuki, John M. Greally

Summary: By studying the gene expression and chromatin states of human fibroblasts infected with Toxoplasma gondii, we gained insights into the molecular interactions between the intracellular pathogen and its host cell. We found that host cell genes were activated to regulate cellular processes, some of which were protective of the host cell while others were advantageous to the pathogen. Analysis of the host and parasite genomic information allowed us to annotate the T. gondii genome more accurately and discover new genes and cis-regulatory elements. By inferring the involved transcription factors and cell signaling responses in the host cell, we could understand how T. gondii perturbs host cell physiology.

PLOS ONE (2022)

Article Rheumatology

Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?

Melissa J. Fazzari, Marta M. Guerra, Jane Salmon, Mimi Y. Kim

Summary: This study aimed to improve the prediction of adverse pregnancy outcomes (APO) in patients with systemic lupus erythematosus (SLE) using machine learning approaches and identify other risk factors. By comparing different algorithms, it was found that some machine learning methods and LASSO performed better in predicting APO. However, further research is needed to discover new biomarkers and risk factors for better prediction.

LUPUS SCIENCE & MEDICINE (2022)

Meeting Abstract Hematology

Molecular Characterization of Adult Acute Lymphoblastic Leukemia Identifies a Subgroup with Myeloid Mutations and Pre-Existing Clonal Hematopoiesis

Caner Saygin, Jacob Stauber, Ibrahim Aldoss, Adam S. Sperling, Lachelle D. Weeks, Marlise R. Luskin, Todd C. Knepper, Pankhuri Wanjari, Peng Wang, Angela Lager, Jeremy Segal, Benjamin Kaumeyer, Sandeep Gurbuxani, Girish Venkataraman, Jason Xiaojun Cheng, Bartholomew Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Olatoyosi Odenike, Richard A. Larson, Lucy A. Godley, Daniel A. Arber, Benjamin L. Ebert, John M. Greally, Ulrich G. Steidl, Bijal D. Shah, Wendy Stock

BLOOD (2022)

Article Genetics & Heredity

Return of non-ACMG recommended incidental genetic findings to pediatric patients: considerations and opportunities from experiences in genomic sequencing

Kevin M. Bowling, Michelle L. Thompson, Melissa A. Kelly, Sarah Scollon, Anne M. Slavotinek, Bradford C. Powell, Brian M. Kirmse, Laura G. Hendon, Kyle B. Brothers, Bruce R. Korf, Gregory M. Cooper, John M. Greally, Anna C. E. Hurst

Summary: The uptake of exome/genome sequencing has introduced challenges related to unexpected testing results, especially for pediatric patients, sparking debate on whether incidental findings should be returned. Identification and return of non-ACMG-recommended incidental findings in pediatric patients can be complex and difficult. While returning incidental genetic findings can benefit patients and providers, challenges and risks are also present.

GENOME MEDICINE (2022)

Review Genetics & Heredity

Using epigenomics to understand cellular responses to environmental influences in diseases

Julia J. Wattacheril, Srilakshmi Raj, David A. Knowles, John M. Greally

Summary: It is believed that environmental influences can affect gene expression by altering epigenetic regulators of transcription. These epigenetic changes can be maintained long term and through cell division, resulting in a prolonged effect of the exposure. The evidence supporting this model comes from the observation of changes in molecular regulators of transcription following exposures. However, this model may be oversimplistic, and further research is needed to fully understand the complex associations between environmental exposures and phenotypes.

PLOS GENETICS (2023)

No Data Available